SCHEMBL13310414

SCHEMBL13310414

COC(=O)NCCCN1C(=O)C=CC1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 6/20 0.50
▸ FAAH O00519 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.48
▸ HPGD P15428 2/20 0.48
▸ HSP90AA1 P07900 1/20 0.48
▸ TLR9 Q9NR96 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ TP53 P04637 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ PKM P14618 1/20 0.48
▸ XBP1 P17861 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ RECQL P46063 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ GPR35 Q9HC97 1/20 0.48
▸ GPR55 Q9Y2T6 1/20 0.48
▸ PTGS1 P23219 7/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24726775 0.89 AKT1 (0.45) MGLLFAAHALDH1A1HPGDHSP90AA1
SCHEMBL3154615 0.84 TDP1 (0.51) MGLLFAAHHSP90AA1TLR9
SCHEMBL825245 0.80 EPHX1 (0.39) MGLLFAAHALDH1A1HPGDHSP90AA1
SCHEMBL3794652 0.80 MGLL (0.56) MGLLFAAHALDH1A1HPGDHSP90AA1
SCHEMBL3270615 0.80 MGLL (0.56) MGLLFAAHALDH1A1HPGDHSP90AA1
SCHEMBL1449045 0.80 TDP1 (0.54) MGLLFAAHALDH1A1HPGDHSP90AA1
SCHEMBL12203264 0.79 MGLL (0.50) MGLLFAAHALDH1A1HPGDHSP90AA1
SCHEMBL17738032 0.79 TDP1 (0.56) MGLLFAAHALDH1A1HPGDHSP90AA1
SCHEMBL17768963 0.79 TSHR (0.45) MGLLFAAHALDH1A1HPGDHSP90AA1
SCHEMBL7801592 0.79 TDP1 (0.56) MGLLFAAHALDH1A1HPGDHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1400550-B1 BRANCHED POLYALKYLENE GLYCOLS KYOWA HAKKO KIRIN CO LTD (JP) 2010-06-23 — — EP disclosed
US-7547765-B2 Branched polyalkylene glycols KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-06-16 — — US disclosed
US-7547765-B2 Branched polyalkylene glycols KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-06-16 — — US disclosed
US-20080125350-A1 BRANCHED POLYALKYLENE GLYCOLS KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-05-29 — — US disclosed
US-20080125350-A1 BRANCHED POLYALKYLENE GLYCOLS KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-05-29 — — US disclosed
US-7291713-B2 Branched polyalkylene glycols KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-11-06 — — US disclosed
US-7291713-B2 Branched polyalkylene glycols KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-11-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125350-A1 BRANCHED POLYALKYLENE GLYCOLS LNPEP, ANPEP, ENPEP MGLL 14/4885FAAH 522/4885ALDH1A1 2967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback